Philippe Kieffer-Kwon

Philippe is Sr. Director of the technological platform at GentiBio. Prior to joining GentiBio, Philippe was the Director of the T-Cell Engineering team at TCR2 Therapeutics. There and at Intrexon Corporation before, he developed allogeneic T-Cell therapies in the field of immuno-oncology. Initially trained in genome editing at the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS, NIH, Bethesda). Philippe brings a decade of experience in genome editing and T-cell engineering and more than 20 years of experience in molecular biology and vector design. Philippe received an engineering degree and a Ph.D. in Molecular and Cellular Biology from the Louis Pasteur University (ULP, France).